Clearance and Safety of the Radiocontrast Medium Iopamidol in Peritoneal Dialysis Patients

Table 2

Patient characteristics for clearance analysis of iopamidol. Patients were divided into two groups based on their residual renal function (RRF). RRF was defined by a urine volume of more than 400 mL/day. BMI: body mass index.

Clearance analysis	All	RRF (+)	RRF (−)
𝑛	11	2	9
Age	62.4±12.6	61.0±13.6	68.5±3.5
Gender (M/F)	6/5	1/1	5/4
Diabetes mellitus (+/−)	5/6	1/1	4/5
Dialysis duration (M)	57.8±23.3	64.0±15.6	51.4±25.2
Dialysate (L/day)	8.58±1.22	7.80±1.19	8.76±1.22
BMI	22.1±3.55	21.8±2.20	22.2±3.89
Crea (mg/dL)	9.80±2.66	7.40±1.41	10.3±2.61
eGFR (mL/min/1.73m^2)	4.56±1.03	5.61±0.10	4.32±0.99
Urine volume (mL/day)	85.0±182	450±70.7	3.89±7.82
Iopamidol administration (mL/body)	50.0±0.00	50.0±0.00	50.0±0.00
Plasma elimination ratio (%)*	83.6±7.60	93.7±3.90	80.1±5.88
𝑇1/2 (hours)	33.3±9.67	21.9±2.92	35.8±8.71
Dialysate concentration*	0.10±0.04	0.06±0.01	0.11±0.04

*at day 4.